Filing Flows › Bausch & Lomb (BLCO) › Q3 2026 › vs Q2 2026
Bausch & Lomb (BLCO) Q3 2026 vs Q2 2026 (quarter over quarter)
Bausch & Lomb's revenue fell $19.0M (-1%) from $1.4B in Q2 2026 to $1.4B in Q3 2026. The biggest changes: Product sales −$18.0M (-1%); Other revenues −$1.0M (-20%); Other revenues −$1.0M (-20%). Operating margin 11.3% against 6.0% (+5.3 pts).
Bausch & Lomb, Q3 2026: revenue $1.4B (+7% year over year), operating margin 11.3%, net earnings $32.0M, operating cash flow $233M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 11.3% | 6.0% | +5.3 pts |
| Net margin | 2.3% | -1.0% | +3.3 pts |
| Free cash flow margin | 12.9% | 5.9% | +7.1 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Devices | $517M | $524M | −$7.0M | -1% |
| OTC | $477M | $497M | −$20.0M | -4% |
| Pharmaceuticals | $319M | $300M | $19.0M | +6% |
| Branded and Other Generics | $58.0M | $68.0M | −$10.0M | -15% |
| Product sales | $1.4B | $1.4B | −$18.0M | -1% |
| Other revenues | $4.0M | $5.0M | −$1.0M | -20% |
| Other revenues | $4.0M | $5.0M | −$1.0M | -20% |
| Revenue | $1.4B | $1.4B | −$19.0M | -1% |
| Operating profit | $155M | $83.0M | $72.0M | +87% |
| Costs & expenses | $1.2B | $1.3B | −$91.0M | -7% |
| Pre-tax earnings | $58.0M | −$11.0M | $69.0M | — |
| Other expense, net | $97.0M | $94.0M | $3.0M | +3% |
| Research & development | $91.0M | $114M | −$23.0M | -20% |
| SG&A | $556M | $588M | −$32.0M | -5% |
| Other operating costs | $573M | $609M | −$36.0M | -6% |
| Net earnings | $32.0M | −$14.0M | $46.0M | — |
| Minority interests | $3.0M | $4.0M | −$1.0M | -25% |
| Income tax | $23.0M | −$1.0M | $24.0M | — |
| Depreciation & amortization | $102M | $102M | $0 | 0% |
| Share-based compensation | $37.0M | $38.0M | −$1.0M | -3% |
| Working capital & other | $62.0M | $27.0M | $35.0M | +130% |
| Operating cash flow | $233M | $153M | $80.0M | +52% |
| Free cash flow (OCF − capex) | $178M | $82.0M | $96.0M | +117% |
| Capital expenditures | $55.0M | $71.0M | −$16.0M | -23% |
Questions
How much did Bausch & Lomb's revenue grow quarter over quarter in Q3 2026?
Bausch & Lomb's revenue fell $19.0M (-1%) from $1.4B in Q2 2026 to $1.4B in Q3 2026.
What drove Bausch & Lomb's revenue change in Q3 2026?
Product sales −$18.0M (-1%); Other revenues −$1.0M (-20%); Other revenues −$1.0M (-20%).